Hypertension Diagnostics, Inc. (HDII)

Hypertension Diagnostics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2018	FY 2017	FY 2016	FY 2012	FY 2011
Period Ending	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Jun 30, 2012	Jun 30, 2011
Net Income	-0.13	-0.37	-0.62	-1.26	0.41
Depreciation & Amortization	0.04	0.03	0.03	0.11	-
Other Amortization	-	-	-	0.03	-
Stock-Based Compensation	-	-	-	0.3	0.13
Provision & Write-off of Bad Debts	0	0	0	-	-
Other Operating Activities	0	0	0	-0.23	-0.76
Change in Accounts Receivable	-0.02	-0.02	-0.02	-0.15	-
Change in Inventory	-0	-0	-0	-0.17	-
Change in Accounts Payable	0.02	0.02	0.02	0.17	-
Change in Other Net Operating Assets	-0.3	0.25	0.2	0.21	-0.01
Operating Cash Flow	-0.39	-0.09	-0.38	-1.23	-0.2
Capital Expenditures	-0	-0	-0	-0.63	-
Other Investing Activities	-	-	-	0.25	-0.13
Investing Cash Flow	-0	-0	-0	-0.38	-0.13
Long-Term Debt Issued	0.19	0.18	0.26	0.95	-
Long-Term Debt Repaid	-	-	-	-0.02	-
Net Debt Issued (Repaid)	0.19	0.18	0.26	0.94	-
Issuance of Common Stock	-	-	-	-	0.03
Other Financing Activities	-	-	-	-0.01	-
Financing Cash Flow	0.19	0.18	0.26	0.93	0.03
Net Cash Flow	-0.2	0.1	-0.12	-0.68	-0.3
Free Cash Flow	-0.39	-0.09	-0.39	-1.86	-0.2
Free Cash Flow Margin	-10.32%	-2.39%	-10.85%	-58.78%	-
Free Cash Flow Per Share	-0.01	-0.00	-0.01	-0.03	-0.00
Cash Interest Paid	-	-	-	0.1	-
Levered Free Cash Flow	-0.43	-0.02	-	-1.37	-0.88
Unlevered Free Cash Flow	-0.33	0.08	-	-1.31	-0.88
Change in Net Working Capital	0.37	-0.21	-	0.24	0.78

Source: S&P Global Market Intelligence. Standard template. Financial Sources.